Ludwig Enterprises (LUDG) Return on Capital Employed (2023 - 2026)
Ludwig Enterprises (LUDG) posted Return on Capital Employed of 40.0% for Q1 2026, down 1.26% on a QoQ basis from 40.51% in Q4 2025, and down 1242.0% year-over-year from 3.5% in Q1 2025.
Ludwig Enterprises (LUDG) Return on Capital Employed (2023 - 2026) Analysis & Trends
Ludwig Enterprises' Return on Capital Employed history runs 4 years deep, the most recent figure standing at 40.0% for Q1 2026.
- Quarterly Return on Capital Employed fell 1242.0% year-over-year to 40.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 40.0% (down 1242.0% YoY) and the FY2025 annual result came in at 40.21%, down 1342.0% from the prior year.
- Return on Capital Employed was 40.0% for Q1 2026 at Ludwig Enterprises, down from 40.51% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 54.26% in Q3 2025 and bottomed at 17.54% in Q4 2023.
- A 4-year average of 42.44% and a median of 49.74% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed soared 7144 bps — and 2025, when it tumbled 1339 bps.
- Ludwig Enterprises' Return on Capital Employed stood at 17.54% in 2023, then jumped by 407 bps to 53.9% in 2024, then declined by 25 bps to 40.51% in 2025, then slipped by 1 bps to 40.0% in 2026.
- Business Quant data shows LUDG's Return on Capital Employed at 40.0% in Q1 2026, 40.51% in Q4 2025, and 54.26% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ludwig Enterprises | 3.27 Mn | 3.27 Mn | - | 40.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.00% |
| Dec 31, 2025 | 40.51% |
| Sep 30, 2025 | 54.26% |
| Jun 30, 2025 | 50.10% |
| Mar 31, 2025 | 52.42% |
| Dec 31, 2024 | 53.90% |
| Sep 30, 2024 | 49.38% |
| Jun 30, 2024 | 49.19% |
| Mar 31, 2024 | 52.14% |
| Dec 31, 2023 | -17.54% |